Heart Failure Optimization at Home to Improve Outcomes (Hozho): A Pragmatic Clinical Trial in Navajo Nation
(Hozho Trial)
Trial Summary
What is the purpose of this trial?
Heart failure causes significant morbidity and mortality, particularly in Navajo Nation. There are well-established evidence of improved mortality and lower heart failure hospitalizations with certain pharmacotherapies for heart failure with reduced ejection fraction (HFrEF). However, these medications are underutilized nationally, including in the Indian Health Service which is one important driver of poor heart failure outcomes. Therefore, as part of an EHR-based pragmatic clinic trial, we are implementing and testing a model that identifies American Indian HFrEF patients receiving care at one large Indian Health Service Site who meet clinical criteria for, but are not on appropriate therapy, and implements a model in patients are initiated and titrated on appropriate therapy over the phone with remote tele monitoring using home blood pressure cuff. We will evaluate the impact of this model to improve uptake of GDMT among HFrEF patients.
Research Team
Maricruz Merino, MD
Principal Investigator
Indian Health Service (IHS)
Lauren Eberly, MD, MPH
Principal Investigator
Indian Health Service, Upenn
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- EHR-based GDMT Optimization (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Indian Health Service
Collaborator
Indian Health Service (IHS)
Collaborator